Surges of increased T cell reactivity to an encephalitogenic region of myelin proteolipid protein occur more often in patients with multiple sclerosis than in healthy subjects

J Immunol. 2000 Nov 1;165(9):5322-31. doi: 10.4049/jimmunol.165.9.5322.

Abstract

We have previously shown that patients with multiple sclerosis (MS) have increased T cell responses to the immunodominant region (residues 184-209) of myelin proteolipid protein (PLP). The present study investigated whether this reactivity fluctuates over time and correlates with disease activity. We performed monthly limiting dilution assays for 12-16 mo in four healthy subjects and five patients with relapsing-remitting MS to quantify the frequencies of circulating T cells proliferating in response to PLP(41-58), PLP(184-199), PLP(190-209), myelin basic protein (MBP), MBP(82-100), and tetanus toxoid. Disease activity was monitored by clinical assessment and gadolinium-enhanced magnetic resonance imaging of the brain. There were fluctuations in the frequencies of autoreactive T cells in all subjects. Compared with healthy controls, MS patients had significantly more frequent surges of T cells reactive to the 184-209 region of PLP, but infrequent surges of T cell reactivity to MBP(82-100). There was temporal clustering of the surges of T cell reactivity to MBP(82-100) and MBP, suggesting T cell activation by environmental stimuli. Some clinical relapses were preceded by surges of T cell reactivity to PLP(184-209), and in one patient there was significant correlation between the frequency of T cells reactive to PLP(184-199) and the total number of gadolinium-enhancing magnetic resonance imaging lesions. However, other relapses were not associated with surges of T cell reactivity to the Ags tested. T cells reactive to PLP(184-209) may contribute to the development of some of the CNS lesions in MS.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Amino Acid Sequence
  • Cluster Analysis
  • Female
  • Humans
  • Immunodominant Epitopes / immunology*
  • Longitudinal Studies
  • Lymphocyte Activation / immunology*
  • Lymphocyte Count
  • Male
  • Middle Aged
  • Molecular Sequence Data
  • Multiple Sclerosis / epidemiology
  • Multiple Sclerosis / immunology*
  • Multiple Sclerosis / pathology
  • Myelin Proteolipid Protein / immunology*
  • Peptide Fragments / immunology*
  • Severity of Illness Index
  • T-Lymphocytes / immunology*
  • Time Factors

Substances

  • Immunodominant Epitopes
  • Myelin Proteolipid Protein
  • Peptide Fragments